Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xun Zhao

Showing results (101-110 of 318) with videos related to

Pageof 32
Sort By:
World Journal of Urology|January 11, 2024
Factors predicting indistinct plane of surgical capsule in patients underwent HoLEP proceduresKe Liu, Xun Zhao, Ruotao Xiao, et al.
Molecular Cancer|October 7, 2025
Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodelingShouhua Li, Hengtong Han, Kaili Yang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 26, 2025
Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapyTingting Zhang, Hengtong Han, Tianying Zhang, et al.
The Kaohsiung Journal of Medical Sciences|August 14, 2021
Circ_0087862 promotes the progression of colorectal cancer by sponging miR-142-3p and up-regulating BACH1 expressionBo Huang, De-Jun Cui, Fang Yan, et al.
Frontiers in Immunology|January 8, 2025
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implicationsXiaoxiao Li, Hengtong Han, Kaili Yang, et al.
International Immunopharmacology|November 27, 2024
Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancerShouhua Li, Hengtong Han, Kaili Yang, et al.
Cell Death Discovery|February 25, 2026
The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancerTianying Zhang, Hengtong Han, Yating Zhang, et al.
Biochemical Genetics|July 6, 2023
TET1 is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Papillary Thyroid CancerYong-Xun Zhao, Li-Bin Ma, Ze Yang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|October 7, 2014
[Chemical constituents from barks of Nothopanax delavayi]Qing Yang, Jian Zhang, Sheng Ouyang, et al.
Cellular Signalling|November 7, 2025
Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapyXiaoxiao Li, Hengtong Han, Shouhua Li, et al.
Pageof 32

Showing results (101-110 of 318) with videos related to

Sort By:
Pageof 32
World Journal of Urology|January 11, 2024
Factors predicting indistinct plane of surgical capsule in patients underwent HoLEP proceduresKe Liu, Xun Zhao, Ruotao Xiao, et al.
Molecular Cancer|October 7, 2025
Exosome-mediated metabolic reprogramming: effects on thyroid cancer progression and tumor microenvironment remodelingShouhua Li, Hengtong Han, Kaili Yang, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|September 26, 2025
Oncogenic mutation-driven metabolism-immunity regulatory axis: Potential prospects for thyroid cancer precision therapyTingting Zhang, Hengtong Han, Tianying Zhang, et al.
The Kaohsiung Journal of Medical Sciences|August 14, 2021
Circ_0087862 promotes the progression of colorectal cancer by sponging miR-142-3p and up-regulating BACH1 expressionBo Huang, De-Jun Cui, Fang Yan, et al.
Frontiers in Immunology|January 8, 2025
Crosstalk between thyroid CSCs and immune cells: basic principles and clinical implicationsXiaoxiao Li, Hengtong Han, Kaili Yang, et al.
International Immunopharmacology|November 27, 2024
Emerging role of metabolic reprogramming in the immune microenvironment and immunotherapy of thyroid cancerShouhua Li, Hengtong Han, Kaili Yang, et al.
Cell Death Discovery|February 25, 2026
The molecular mechanisms and potential therapeutic implications of the crosstalk between DNA methylation and metabolic reprogramming in thyroid cancerTianying Zhang, Hengtong Han, Yating Zhang, et al.
Biochemical Genetics|July 6, 2023
TET1 is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Papillary Thyroid CancerYong-Xun Zhao, Li-Bin Ma, Ze Yang, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|October 7, 2014
[Chemical constituents from barks of Nothopanax delavayi]Qing Yang, Jian Zhang, Sheng Ouyang, et al.
Cellular Signalling|November 7, 2025
Cancer-associated fibroblasts: The "Achilles' Heel" in thyroid tumor progression and therapyXiaoxiao Li, Hengtong Han, Shouhua Li, et al.
Pageof 32